Literature DB >> 1376442

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

G J Lieschke1, A W Burgess.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1376442     DOI: 10.1056/NEJM199207093270207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  57 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

3.  Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization.

Authors:  Melissa van Pel; Ronald van Os; Gerjo A Velders; Henny Hagoort; Peter M H Heegaard; Ivan J D Lindley; Roel Willemze; Willem E Fibbe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  A case of granulocyte colony-stimulating factor-producing intrahepatic sarcomatoid cholangiocarcinoma.

Authors:  Akifumi Kuwano; Fumiya Narutomi; Shigehiro Nagasawa; Kosuke Tanaka; Yusuke Morita; Masayoshi Yada; Yoshihiro Ohishi; Akihide Masumoto; Kenta Motomura
Journal:  Clin J Gastroenterol       Date:  2021-03-30

Review 5.  Neutrophil biology and the next generation of myeloid growth factors.

Authors:  David C Dale
Journal:  J Natl Compr Canc Netw       Date:  2009-01       Impact factor: 11.908

6.  Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis.

Authors:  R Badaró; C Nascimento; J S Carvalho; F Badaró; D Russo; J L Ho; S G Reed; W D Johnson; T C Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

Review 7.  The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.

Authors:  Der-Cherng Liang
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

8.  Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.

Authors:  T Lazard; C Perronne; Y Cohen; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

9.  Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF).

Authors:  A Willfort; C Lorber; S Kapiotis; S Sertl; R Hainz; P Kirchweger; U Jäger; P A Kyrle; K Lechner; K Geissler
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

Review 10.  Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.

Authors:  J E Frampton; Y E Yarker; K L Goa
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.